High blood pressure is responsible for the modulation of blood vessel morphology and function. Arterial hypertension is considered to play a significant role in atherosclerotic ischaemic heart disease, stroke and hypertensive nephropathy, whereas high venous pressure causes varicose vein formation and chronic venous insufficiency and contributes to vein bypass graft failure. Hypertension exerts differing injurious forces on the vessel wall, namely shear stress and circumferential stretch. Morphological and molecular changes in blood vessels ascribed to elevated pressure consist of endothelial damage, neointima formation, activation of inflammatory cascades, hypertrophy, migration and phenotypic changes in vascular smooth muscle cells, as well as extracellular matrix imbalances. Differential expression of genes encoding relevant factors including vascular endothelial growth factor, endothelin-1, interleukin-6, vascular cell adhesion molecule, intercellular adhesion molecule, matrix metalloproteinase-2 and -9 and plasminogen activator inhibitor-1 has been explored using ex vivo cellular or organ stretch models and in vivo experimental animal models. Identification of pertinent genes may unravel new therapeutic strategies to counter the effects of pressure-induced stretch on the vessel wall and hence minimise its notable complications.

Keywords:
Gene expression, Arteries, Veins, Stretch, Pressure
1.
Giles TD, et al: Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich) 2005;7:505–512.
2.
Eberhardt RT, Raffetto JD: Chronic venous insufficiency. Circulation 2005;111:2398–409.
3.
Lemarie CA, Tharaux PL, Lehoux S: Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol 2010;48:433–439.
4.
Lehoux S, Tedgui A: Cellular mechanics and gene expression in blood vessels. J Biomech 2003;36:631–643.
5.
Leung DY, Glagov S, Mathews MB: Elastin and collagen accumulation in rabbit ascending aorta and pulmonary trunk during postnatal growth. Correlation of cellular synthetic response with medial tension. Circ Res 1977;41:316–323.
6.
Langille BL, Brownlee RD, Adamson SL: Perinatal aortic growth in lambs: relation to blood flow changes at birth. Am J Physiol 1990;259:H1247–H1253.
7.
Levy BI, et al: Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 1988;63:227–239.
8.
Intengan HD, Schiffrin EL: Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 2001;38:581–587.
9.
Ailawadi G, Eliason JL, Upchurch GR Jr: Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 2003;38:584–588.
10.
Alexander RW: Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995;25:155–161.
11.
Ross R: Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115–126.
12.
Crowther MA: Pathogenesis of atherosclerosis. Hematology Am Soc Hematol Educ Program 2005:436–441.
13.
Cheng C, et al: Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 2006;113:2744–2753.
14.
Thubrikar MJ, Robicsek F: Pressure-induced arterial wall stress and atherosclerosis. Ann Thorac Surg 1995;59:1594–603.
15.
Raffetto JD, Khalil RA: Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology 2008;23:85–98.
16.
Bhardwaj S, Roy H, Yla-Herttuala S: Gene therapy to prevent occlusion of venous bypass grafts. Expert Rev Cardiovasc Ther 2008;6:641–652.
17.
Tsui JC, et al: Localization of nitric oxide synthase in saphenous vein grafts harvested with a novel ‘no-touch’ technique: potential role of nitric oxide contribution to improved early graft patency rates. J Vasc Surg 2002;35:356–362.
18.
Ballard JL, Mills JL Sr: Surgical management of critical limb ischemia. Tech Vasc Interv Radiol 2005;8:169–174.
19.
Golledge J: Lower-limb arterial disease. Lancet 1997;350:1459–1465.
20.
Zou Y, et al: Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301–1310.
21.
Parang P, Arora R: Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol 2009;25:e57–e62.
22.
Mofidi R, et al: Significance of the early postoperative duplex result in infrainguinal vein bypass surveillance. Eur J Vasc Endovasc Surg 2007;34:327–332.
23.
Szilagyi DE, et al: Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg 1973;178:232–246.
24.
O’Rourke M: Mechanical principles in arterial disease. Hypertension 1995;26:2–9.
25.
Boutouyrie P, et al: Opposing effects of ageing on distal and proximal large arteries in hypertensives. J Hypertens Suppl 1992;10:S87–S91.
26.
Lehoux S, Castier Y, Tedgui A: Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med 2006;259:381–392.
27.
Haga JH, Li YS, Chien S: Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech 2007;40:947–960.
28.
Hurley NE, et al: Modulating the functional contributions of c-Myc to the human endothelial cell cyclic strain response. J Vasc Res 2010;47:80–90.
29.
Chang H, et al: Regulation of hypoxia-inducible factor-1alpha by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond) 2003;105:447–456.
30.
Cheng JJ, et al: Cyclic strain enhances adhesion of monocytes to endothelial cells by increasing intercellular adhesion molecule-1 expression. Hypertension 1996;28:386–391.
31.
Lim CS, et al: Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. J Vasc Surg 2011;53:764–773.
32.
de Waard V, et al: TR3 nuclear orphan receptor prevents cyclic stretch-induced proliferation of venous smooth muscle cells. Am J Pathol 2006;168:2027–2035.
33.
Nichol JW, et al: Hemodynamics and axial strain additively increase matrix remodeling and MMP-9, but not MMP-2, expression in arteries engineered by directed remodeling. Tissue Eng Part A 2009;15:1281–1290.
34.
Misra S, et al: The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis. J Vasc Interv Radiol 2008;19:587–594.
35.
Chung AW, et al: Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9. J Vasc Surg 2005;42:747–756.
36.
Lehoux S, Tedgui A: Signal transduction of mechanical stresses in the vascular wall. Hypertension 1998;32:338–345.
37.
Hill MA, et al: Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacol Sci 2009;30:363–374.
38.
Hoffman BD, Grashoff C, Schwartz MA: Dynamic molecular processes mediate cellular mechanotransduction. Nature 2011;475:316–323.
39.
Numaguchi K, et al: Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res 1999;85:5–11.
40.
Li C, et al: Ras/Rac-Dependent activation of p38 mitogen-activated protein kinases in smooth muscle cells stimulated by cyclic strain stress. Arterioscler Thromb Vasc Biol 2000;20:E1–E9.
41.
Sotoudeh M, et al: Induction of apoptosis in vascular smooth muscle cells by mechanical stretch. Am J Physiol Heart Circ Physiol 2002;282:H1709–H1716.
42.
Li Y, et al: Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. Cell Signal 2000;12:751–757.
43.
Birukov KG, et al: Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture. Circ Res 1997;81:895–903.
44.
Wung BS, et al: Modulation of Ras/Raf/extracellular signal-regulated kinase pathway by reactive oxygen species is involved in cyclic strain-induced early growth response-1 gene expression in endothelial cells. Circ Res 1999;84:804–812.
45.
Du W, Mills I, Sumpio BE: Cyclic strain causes heterogeneous induction of transcription factors, AP-1, CRE binding protein and NF-ĸB, in endothelial cells: species and vascular bed diversity. J Biomech 1995;28:1485–1491.
46.
Zheng W, Christensen LP, Tomanek RJ: Stretch induces upregulation of key tyrosine kinase receptors in microvascular endothelial cells. Am J Physiol Heart Circ Physiol 2004;287:H2739–H2745.
47.
Frye SR, et al: cDNA microarray analysis of endothelial cells subjected to cyclic mechanical strain: importance of motion control. Physiol Genomics 2005;21:124–130.
48.
Ives CL, Eskin SG, McIntire LV: Mechanical effects on endothelial cell morphology: in vitro assessment. In Vitro Cell Dev Biol 1986;22:500–507.
49.
Cheng WP, et al: The molecular regulation of GADD153 in apoptosis of cultured vascular smooth muscle cells by cyclic mechanical stretch. Cardiovasc Res 2008;77:551–559.
50.
Stula M, et al: Influence of sustained mechanical stress on Egr-1 mRNA expression in cultured human endothelial cells. Mol Cell Biochem 2000;210:101–108.
51.
Cornelissen J, Armstrong J, Holt CM: Mechanical stretch induces phosphorylation of p38-MAPK and apoptosis in human saphenous vein. Arterioscler Thromb Vasc Biol 2004;24:451–456.
52.
Goldman J, Zhong L, Liu SQ: Degradation of alpha-actin filaments in venous smooth muscle cells in response to mechanical stretch. Am J Physiol Heart Circ Physiol 2003;284:H1839–H1847.
53.
Mayr M, et al: Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J 2002;16:1423–1425.
54.
Iwasaki H, et al: Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor. Am J Physiol Heart Circ Physiol 2000;278:H521–H529.
55.
Mata-Greenwood E, et al: Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-beta1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am J Physiol Lung Cell Mol Physiol 2005;289:L288–L289.
56.
Milkiewicz M, et al: HIF-1alpha and HIF-2alpha play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle. J Physiol 2007;583:753–766.
57.
Semenza GL: Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009;24:97–106.
58.
Kasivisvanathan V, et al: Hypoxia-inducible factor-1 in arterial disease: a putative therapeutic target. Curr Vasc Pharmacol 2011;9:333–349.
59.
Semenza GL: Vascular responses to hypoxia and ischemia. Arterioscler Thromb Vasc Biol 2010;30:648–652.
60.
Richard MN, et al: Mechanical stretching stimulates smooth muscle cell growth, nuclear protein import, and nuclear pore expression through mitogen-activated protein kinase activation. J Biol Chem 2007;282:23081–23088.
61.
Feng Y, et al: Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. Circ Res 1999;85:1118–1123.
62.
Albinsson S, Nordstrom I, Hellstrand P: Stretch of the vascular wall induces smooth muscle differentiation by promoting actin polymerization. J Biol Chem 2004;279:34849–34855.
63.
Rovner AS, Murphy RA, Owens GK: Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem 1986;261:14740–14745.
64.
Stanley AG, et al: Mechanical strain-induced human vascular matrix synthesis: the role of angiotensin II. J Renin Angiotensin Aldosterone Syst 2000;1:32–35.
65.
Toda M, et al: Differential gene responses in endothelial cells exposed to a combination of shear stress and cyclic stretch. J Biotechnol 2008;133:239–244.
66.
Tsukurov OI, et al: The response of adult human saphenous vein endothelial cells to combined pressurized pulsatile flow and cyclic strain, in vitro. Ann Vasc Surg 2000;14:260–267.
67.
Cattaruzza M, et al: Stretch-induced endothelin B receptor-mediated apoptosis in vascular smooth muscle cells. FASEB J 2000;14:991–998.
68.
Casey PJ, et al: The effect of combined arterial hemodynamics on saphenous venous endothelial nitric oxide production. J Vasc Surg 2001;33:1199–1205.
69.
Hishikawa K, Luscher TF: Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation 1997;96:3610–3616.
70.
Iba T, et al: Stimulation of endothelial secretion of tissue-type plasminogen activator by repetitive stretch. J Surg Res 1991;50:457–460.
71.
Sumpio BE, Banes AJ: Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic mechanical deformation. Surgery 1988;104:383–389.
72.
Wung BS, et al: Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 1997;81:1–7.
73.
Wojtowicz A, et al: Zyxin mediation of stretch-induced gene expression in human endothelial cells. Circ Res 2010;107:898–902.
74.
Okada M, et al: Cyclic stretch upregulates production of interleukin-8 and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:894–901.
75.
Kobayashi S, et al: Stretch-induced IL-6 secretion from endothelial cells requires NF-kappaB activation. Biochem Biophys Res Commun 2003;308:306–312.
76.
Zampetaki A, et al: Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-kappaB signaling pathways. Am J Physiol Heart Circ Physiol 2005;288:H2946–H2954.
77.
Zhao H, et al: Cyclic stretch induces cyclooxygenase-2 gene expression in vascular endothelial cells via activation of nuclear factor kappa-beta. Biochem Biophys Res Commun 2009;389:599–601.
78.
Huang G, et al: Mechanical strain induces expression of C-reactive protein in human blood vessels. J Pharmacol Exp Ther 2009;330:206–211.
79.
Lusic I, et al: Is C-reactive protein a better predictor of recurrent carotid disease following carotid endarterectomy than established risk factors for atherosclerosis? Vasa 2006;35:221–225.
80.
Verma S, Devaraj S, Jialal I: Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006;113:2135–2150, discussion 2150.
81.
Psychari SN, et al: Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005;95:764–767.
82.
Vainas T, et al: Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003;107:1103–1105.
83.
Parolari A, et al: Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg 2007;84:823–828.
84.
Prasad K: C-reactive protein increases oxygen radical generation by neutrophils. J Cardiovasc Pharmacol Ther 2004;9:203–209.
85.
Hobeika MJ, et al: Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg 2007;45:849–857.
86.
Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827–839.
87.
Lim CS, et al: Matrix metalloproteinases in vascular disease – a potential therapeutic target? Curr Vasc Pharmacol 2010;8:75–85.
88.
Raffetto JD, Khalil RA: Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008;75:346–359.
89.
Vartak DG, Gemeinhart RA: Matrix metalloproteases: underutilized targets for drug delivery. J Drug Target 2007;15:1–20.
90.
Tamura K, et al: Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells. J Biol Chem 2000;275:34619–34627.
91.
Wang BW, et al: Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells. Cardiovasc Res 2003;59:460–469.
92.
Milkiewicz M, Haas TL: Effect of mechanical stretch on HIF-1{alpha} and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol 2005;289:H1315–H1320.
93.
Grote K, et al: Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 2003;92:e80–e86.
94.
Zhou D, et al: Differential MMP-2 activity of ligament cells under mechanical stretch injury: an in vitro study on human ACL and MCL fibroblasts. J Orthop Res 2005;23:949–957.
95.
Asanuma K, et al: Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2003;284:H1778–H1784.
96.
Raffetto JD, et al: Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: potential implications in varicose veins. J Vasc Surg 2008;48:447–456.
97.
Raffetto JD, Ross RL, Khalil RA: Matrix metalloproteinase 2-induced venous dilation via hyperpolarization and activation of K+ channels: relevance to varicose vein formation. J Vasc Surg 2007;45:373–380.
98.
Lim CS, et al: Prolonged mechanical stretch is associated with upregulation of hypoxia-inducible factors and reduced contraction in rat inferior vena cava. J Vasc Surg 2011;53:764–773.
99.
Ruddy JM, et al: Differential effect of wall tension on matrix metalloproteinase promoter activation in the thoracic aorta. J Surg Res 2010;160:333–339.
100.
Pascarella L, et al: Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg. Eur J Vasc Endovasc Surg 2008;35:102–110.
101.
Cheng J, et al: The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ Res 2010;107:1265–1274.
102.
Pascarella L, Schmid-Schonbein GW, Bergan J: An animal model of venous hypertension: the role of inflammation in venous valve failure. J Vasc Surg 2005;41:303–311.
103.
Takase S, et al: Hypertension-induced venous valve remodeling. J Vasc Surg 2004;39:1329–1334.
104.
Birukov KG: Cyclic stretch, reactive oxygen species, and vascular remodeling. Antioxid Redox Signal 2009;11:1651–1667.
105.
Touyz RM, Schiffrin EL: Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004;122:339–352.
106.
Ali MH, Mungai PT, Schumacker PT: Stretch-induced phosphorylation of focal adhesion kinase in endothelial cells: role of mitochondrial oxidants. Am J Physiol Lung Cell Mol Physiol 2006;291:L38–L45.
107.
Amma H, et al: Involvement of reactive oxygen species in cyclic stretch-induced NF-kappaB activation in human fibroblast cells. Br J Pharmacol 2005;145:364–373.
108.
Cai H, Griendling KK, Harrison DG: The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003;24:471–478.
109.
Ushio-Fukai M, et al: p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998;273:15022–15029.
110.
Lehoux S, et al: Pulsatile stretch-induced extracellular signal-regulated kinase 1/2 activation in organ culture of rabbit aorta involves reactive oxygen species. Arterioscler Thromb Vasc Biol 2000;20:2366–2372.
111.
Lemarie CA, et al: Transforming growth factor-alpha mediates nuclear factor kappaB activation in strained arteries. Circ Res 2006;99:434–441.
112.
Chen Q, et al: Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase. J Vasc Surg 2003;37:660–668.
113.
Laurikka JO, et al: Risk indicators for varicose veins in forty- to sixty-year-olds in the Tampere varicose vein study. World J Surg 2002;26:648–651.
114.
Somers P, Knaapen M: The histopathology of varicose vein disease. Angiology 2006;57:546–555.
115.
Gillespie DL, et al: Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res 2002;106:233–238.
116.
Aunapuu M, Arend A: Histopathological changes and expression of adhesion molecules and laminin in varicose veins. Vasa 2005;34:170–175.
117.
Sayer GL, Smith PD: Immunocytochemical characterisation of the inflammatory cell infiltrate of varicose veins. Eur J Vasc Endovasc Surg 2004;28:479–483.
118.
Saharay M, et al: Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998;15:342–349.
119.
Takase S, Bergan JJ, Schmid-Schonbein G: Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000;14:427–435.
120.
Signorelli SS, et al: Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage. Clin Hemorheol Microcirc 2000;22:311–316.
121.
Gohel MS, et al: The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J Vasc Surg 2008;48:1272–1277.
122.
Jacob MP, et al: Plasma matrix metalloproteinase-9 as a marker of blood stasis in varicose veins. Circulation 2002;106:535–538.
123.
Davies AH, et al: Pre-bypass morphological changes in vein grafts. Eur J Vasc Surg 1993;7:642–764.
124.
Wilson YG, et al: Vein quality influences neointimal hyperplasia in an organ culture model of human saphenous vein. Eur J Vasc Endovasc Surg 1997;13:557–562.
125.
Pyle AL, et al: Biomechanical stress induces novel arterial intima-enriched genes: implications for vascular adaptation to stress. Cardiovasc Pathol 2010;19:e13–e20.
126.
McMillan WD, et al: Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 1997;96:2228–2232.
127.
Shalhoub J, et al: Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm (Lond) 2011;8:9.
128.
Martinez R, et al: Mechanical buckling of veins under internal pressure. Ann Biomed Eng 2010;38:1345–1353.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.